Travere Therapeutics to Present at the Guggenheim Emerging Outlook Biotech Summit View Full Press Release Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) Travere Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)